BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28877678)

  • 1. Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
    Tomoka T; Powers E; van der Gronde T; Amuquandoh A; Dhungel BM; Kampani C; Kamiza S; Montgomery ND; Fedoriw Y; Gopal S
    BMC Cancer; 2017 Sep; 17(1):633. PubMed ID: 28877678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
    Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
    BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
    Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
    Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
    Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
    Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.
    Hayashino K; Yoshida C; Ayata Y; Yukawa R; Komura A; Nakamura M; Meguri Y; Yamamoto K; Oda W; Imajo K
    J Clin Exp Hematop; 2024; 64(1):52-58. PubMed ID: 38538319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
    Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
    Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Epstein-Barr virus associated NK/T cell lymphoma after immunosuppressive therapy for aplastic anemia: report of a case and review of literature.
    Yin G; Ni Y; Xiao Z; He G; Miao K
    Int J Clin Exp Pathol; 2015; 8(6):7588-93. PubMed ID: 26261674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
    Zheng W; Gao Y; Ke X; Zhang W; Su L; Ren H; Lin N; Xie Y; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
    BMC Cancer; 2018 Sep; 18(1):910. PubMed ID: 30241515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
    Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
    Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
    Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
    Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal natural killer/T-cell lymphoma, nasal type, in Senegal.
    Diallo M; Diop A; Diatta BA; Ndiaye M; Ortonne N; Dieng MT
    Int J Dermatol; 2018 Apr; 57(4):401-405. PubMed ID: 29380871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
    Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S
    Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal natural killer/T-cell lymphoma, nasal-type.
    Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
    Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
    Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
    Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous effusion cytology of extranodal natural killer/T-cell lymphoma.
    Su XY; Huang J; Jiang Y; Tang Y; Li GD; Liu WP
    Cytopathology; 2012 Apr; 23(2):96-102. PubMed ID: 22035150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.
    Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS
    Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
    Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.